|
|
||||||||
Clinical Chemistry, Vol 38, 11-18, Copyright © 1992 by American Association for Clinical Chemistry
ND Christofides, CP Sheehan and JE Midgley
Amerlite Diagnostics Ltd., Cardiff Laboratories, Whitchurch, U.K.
We describe a one-step, labeled-antibody radioassay for measuring free thyroxin (FT4) in serum or plasma, based on a novel principle. FT4 in the sample competes with a gross molar excess (over antibody) of a cross-reactant (L-triiodothyronine, T3), chemically coupled to magnetizable polymer particles, for binding to avid 125l-labeled monoclonal anti-thyroxin antibodies. As in conventional immunoassays, 125I counts bound to the solid phase (T3-magnetizable particles) are inversely proportional to sample FT4 concentration. We demonstrate here the development and technical validity of this new method.
The following articles in journals at HighWire Press have cited this article:
![]() |
J. E.M. Midgley and N. D. Christofides Point: Legitimate and Illegitimate Tests of Free-Analyte Assay Function Clin. Chem., March 1, 2009; 55(3): 439 - 441. [Full Text] [PDF] |
||||
![]() |
J. E.M. Midgley Direct and Indirect Free Thyroxine Assay Methods: Theory and Practice Clin. Chem., August 1, 2001; 47(8): 1353 - 1363. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |